Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Nat Commun ; 11(1): 1990, 2020 04 24.
Artículo en Inglés | MEDLINE | ID: mdl-32332749

RESUMEN

Up-regulation of utrophin in muscles represents a promising therapeutic strategy for the treatment of Duchenne Muscular Dystrophy. We previously demonstrated that eEF1A2 associates with the 5'UTR of utrophin A to promote IRES-dependent translation. Here, we examine whether eEF1A2 directly regulates utrophin A expression and identify via an ELISA-based high-throughput screen, FDA-approved drugs that upregulate both eEF1A2 and utrophin A. Our results show that transient overexpression of eEF1A2 in mouse muscles causes an increase in IRES-mediated translation of utrophin A. Through the assessment of our screen, we reveal 7 classes of FDA-approved drugs that increase eEF1A2 and utrophin A protein levels. Treatment of mdx mice with the 2 top leads results in multiple improvements of the dystrophic phenotype. Here, we report that IRES-mediated translation of utrophin A via eEF1A2 is a critical mechanism of regulating utrophin A expression and reveal the potential of repurposed drugs for treating DMD via this pathway.


Asunto(s)
Distrofia Muscular de Duchenne/tratamiento farmacológico , Factor 1 de Elongación Peptídica/antagonistas & inhibidores , Biosíntesis de Proteínas/efectos de los fármacos , Utrofina/genética , Regiones no Traducidas 5'/genética , Animales , Betaxolol/farmacología , Betaxolol/uso terapéutico , Línea Celular , Modelos Animales de Enfermedad , Evaluación Preclínica de Medicamentos , Reposicionamiento de Medicamentos , Humanos , Sitios Internos de Entrada al Ribosoma/genética , Ratones , Ratones Endogámicos mdx , Ratones Noqueados , Distrofia Muscular de Duchenne/genética , Mioblastos , Factor 1 de Elongación Peptídica/genética , Factor 1 de Elongación Peptídica/metabolismo , Pravastatina/farmacología , Pravastatina/uso terapéutico , Biosíntesis de Proteínas/genética , Regulación hacia Arriba/efectos de los fármacos , Utrofina/metabolismo
2.
Sci Transl Med ; 11(516)2019 10 30.
Artículo en Inglés | MEDLINE | ID: mdl-31666401

RESUMEN

Human enterovirus A71 (HEVA71) causes hand, foot, and mouth disease (HFMD) in young children and is considered a major neurotropic pathogen but lacks effective antivirals. To identify potential therapeutic agents against HFMD, we screened a 502-compound flavonoid library for compounds targeting the HEVA71 internal ribosome entry site (IRES) that facilitates translation of the HEVA71 genome and is vital for the production of HEVA71 viral particles. We validated hits using cell viability and viral plaque assays and found that prunin was the most potent inhibitor of HEVA71. Downstream assays affirmed that prunin disrupted viral protein and RNA synthesis and acted as a narrow-spectrum antiviral against enteroviruses A and B, but not enterovirus C, rhinovirus A, herpes simplex 1, or chikungunya virus. Continuous HEVA71 passaging with prunin yielded HEVA71-resistant mutants with five mutations that mapped to the viral IRES. Knockdown studies showed that the mutations allowed HEVA71 to overcome treatment-induced suppression by differentially regulating recruitment of the IRES trans-acting factors Sam68 and hnRNPK without affecting the hnRNPA1-IRES interaction required for IRES translation. Furthermore, prunin effectively reduced HEVA71-associated clinical symptoms and mortality in HEVA71-infected BALB/c mice and suppressed hepatitis C virus at higher concentrations, suggesting a similar mechanism of prunin-mediated IRES inhibition for both viruses. These studies establish prunin as a candidate for further development as a HEVA71 therapeutic agent.


Asunto(s)
Enterovirus Humano A/fisiología , Infecciones por Enterovirus/tratamiento farmacológico , Infecciones por Enterovirus/virología , Sitios Internos de Entrada al Ribosoma , Florizina/análogos & derivados , Animales , Antibacterianos/farmacología , Muerte Celular/efectos de los fármacos , Proteínas de Unión al ADN/metabolismo , Evaluación Preclínica de Medicamentos , Farmacorresistencia Viral/efectos de los fármacos , Farmacorresistencia Viral/genética , Flavonoides/farmacología , Genes Reporteros , Hepacivirus/efectos de los fármacos , Ribonucleoproteína Nuclear Heterogénea A1/metabolismo , Humanos , Sitios Internos de Entrada al Ribosoma/genética , Luciferasas/metabolismo , Ratones Endogámicos BALB C , Mutación/genética , Florizina/farmacología , Florizina/uso terapéutico , Reproducibilidad de los Resultados , Replicación Viral/efectos de los fármacos
3.
Bioorg Med Chem Lett ; 29(22): 126729, 2019 11 15.
Artículo en Inglés | MEDLINE | ID: mdl-31607608

RESUMEN

Wheat germ extract (WGE) is one of the most widely used eukaryotic cell-free translation systems for easy synthesis of a broad range of proteins merely by adding template mRNAs. Its productivity has thus far been improved by removing translational inhibitors from the extract and stabilizing the template with terminal protectors. Nonetheless, there remains room for increasing the yield by designing a terminally protected template with higher susceptibility to translation. Given the fact that a 5' terminal protector is a strong inhibitor of the canonical translation, we herein focused on Cripavirus internal ribosome entry sites (IRESes), which allow for a unique translation initiation from a non-AUG start codon without the help of any initiation factors. We mutated their start codons to enhance the IRES-mediated translation efficiency in WGE. One of the mutants showed considerably higher efficiency, 3-4-fold higher than that of its wild type, and also 3-4-fold higher than the canonical translation efficiency by an IRES-free mRNA having one of the most effective canonical-translation enhancers. Because this mutated IRES is compatible with different types of genes and terminal protectors, we expect it will be widely used to synthesize proteins in WGE.


Asunto(s)
Codón Iniciador/genética , Dicistroviridae/genética , Sitios Internos de Entrada al Ribosoma/genética , Extractos Vegetales/genética , Biosíntesis de Proteínas/genética , Triticum/genética , Relación Dosis-Respuesta a Droga , Estructura Molecular , Mutación , Relación Estructura-Actividad
4.
J Virol ; 93(9)2019 05 01.
Artículo en Inglés | MEDLINE | ID: mdl-30814282

RESUMEN

Enterovirus 71 (EV-A71) is a human pathogen that causes hand, foot, and mouth disease (HFMD) and fatal neurological diseases, and no effective treatment is available. Characterization of key host factors is important for understanding its pathogenesis and developing antiviral drugs. Here we report that Hsp27 is one of the most upregulated proteins in response to EV-A71 infection, as revealed by two-dimensional gel electrophoresis-based proteomics studies. Depletion of Hsp27 by small interfering RNA or CRISPR/Cas9-mediated knockout significantly inhibited viral replication, protein expression, and reproduction, while restoration of Hsp27 restored such virus activities. Furthermore, we show that Hsp27 plays a crucial role in regulating viral internal ribosome entry site (IRES) activities by two different mechanisms. Hsp27 markedly promoted 2Apro-mediated eukaryotic initiation factor 4G cleavage, an important process for selecting and initiating IRES-mediated translation. hnRNP A1 is a key IRES trans-acting factor (ITAF) for enhancing IRES-mediated translation. Surprisingly, knockout of Hsp27 differentially blocked hnRNP A1 but not FBP1 translocation from the nucleus to the cytoplasm and therefore abolished the hnRNP A1 interaction with IRES. Most importantly, the Hsp27 inhibitor 1,3,5-trihydroxy-13,13-dimethyl-2H-pyran [7,6-b] xanthone (TDP), a compound isolated from a traditional Chinese herb, significantly protected against cytopathic effects and inhibited EV-A71 infection. Collectively, our results demonstrate new functions of Hsp27 in facilitating virus infection and provide novel options for combating EV-A71 infection by targeting Hsp27.IMPORTANCE Outbreaks of infections with EV-A71, which causes hand, foot, and mouth disease, severe neurological disorders, and even death, have been repeatedly reported worldwide in recent decades and are a great public health problem for which no approved treatments are available. We show that Hsp27, a heat shock protein, supports EV-A71 infection in two distinct ways to promote viral IRES-dependent translation. A small-molecule Hsp27 inhibitor isolated from a traditional Chinese medicinal herb effectively reduces virus yields. Together, our findings demonstrate that Hsp27 plays an important role in EV-A71 infection and may serve as an antiviral target.


Asunto(s)
Enterovirus Humano A/fisiología , Infecciones por Enterovirus/metabolismo , Regulación Viral de la Expresión Génica , Proteínas de Choque Térmico/metabolismo , Sitios Internos de Entrada al Ribosoma , Chaperonas Moleculares/metabolismo , Biosíntesis de Proteínas , Proteínas Virales/biosíntesis , Replicación Viral/fisiología , Línea Celular Tumoral , Núcleo Celular/genética , Núcleo Celular/metabolismo , Núcleo Celular/virología , Citoplasma/genética , Citoplasma/metabolismo , Citoplasma/virología , Factor 4G Eucariótico de Iniciación/genética , Factor 4G Eucariótico de Iniciación/metabolismo , Fructosa-Bifosfatasa/genética , Fructosa-Bifosfatasa/metabolismo , Técnicas de Inactivación de Genes , Proteínas de Choque Térmico/genética , Ribonucleoproteína Nuclear Heterogénea A1/genética , Ribonucleoproteína Nuclear Heterogénea A1/metabolismo , Humanos , Chaperonas Moleculares/genética , Proteínas Virales/genética
5.
PLoS One ; 13(1): e0191617, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-29370243

RESUMEN

EV71 is a positive-sense single-stranded RNA virus that belongs to the Picornaviridae family. EV71 infection may cause various symptoms ranging from hand-foot-and-mouth disease to neurological pathological conditions such as aseptic meningitis, ataxia, and acute transverse myelitis. There is currently no effective treatment or vaccine available. Various compounds have been examined for their ability to restrict EV71 replication. However, most experiments have been performed in rhabdomyosarcoma or Vero cells. Since the gastrointestinal tract is the entry site for this pathogen, we anticipated that orally ingested agents may exert beneficial effects by decreasing virus replication in intestinal epithelial cells. In this study, curcumin (diferuloylmethane, C21H20O6), an active ingredient of turmeric (Curcuma longa Linn) with anti-cancer properties, was investigated for its anti-enterovirus activity. We demonstrate that curcumin treatment inhibits viral translation and increases host cell viability. Curcumin does not exert its anti-EV71 effects by modulating virus attachment or virus internal ribosome entry site (IRES) activity. Furthermore, curcumin-mediated regulation of mitogen-activated protein kinase (MAPK) signaling pathways is not involved. We found that protein kinase C delta (PKCδ) plays a role in virus translation in EV71-infected intestinal epithelial cells and that curcumin treatment decreases the phosphorylation of this enzyme. In addition, we show evidence that curcumin also limits viral translation in differentiated human intestinal epithelial cells. In summary, our data demonstrate the anti-EV71 properties of curcumin, suggesting that ingestion of this phytochemical may protect against enteroviral infections.


Asunto(s)
Curcumina/metabolismo , Curcumina/uso terapéutico , Infecciones por Enterovirus/tratamiento farmacológico , Línea Celular , Curcumina/farmacología , Enterovirus/efectos de los fármacos , Enterovirus Humano A/genética , Infecciones por Enterovirus/virología , Células Epiteliales/efectos de los fármacos , Células HT29 , Enfermedad de Boca, Mano y Pie/metabolismo , Interacciones Huésped-Patógeno , Humanos , Sitios Internos de Entrada al Ribosoma , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/metabolismo , Mucosa Intestinal/microbiología , Intestinos/efectos de los fármacos , Biosíntesis de Proteínas/efectos de los fármacos , ARN Viral/genética , Proteínas Virales/genética , Replicación Viral/efectos de los fármacos
6.
Antiviral Res ; 150: 60-68, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29233744

RESUMEN

Hand Foot Mouth Disease (HFMD), resulting from human enterovirus A71 (HEVA71) infection can cause severe neurological complications leading to fatality in young children. Currently, there is no approved antiviral for therapeutic treatment against HEVA71 infection. In this study, a 500-compound flavonoid library was screened to identify potential inhibitors of HEVA71 using high-throughput immunofluorescence-based phenotypic screening method. Two lead flavonoid compounds, ST077124 and ST024734 at the non-cytotoxic concentration of 50 µM were found to be effective antivirals that inhibited replication of HEVA71, reducing infectious viral titers by 3.5 log10 PFU/ml and 2.5 log10 PFU/ml respectively. Our study revealed that ST077124 is a specific antiviral compound that inhibits human enteroviruses while ST024734 exhibited antiviral activity against human enteroviruses as well as dengue virus type-2. We also identified that both compounds affected the viral RNA transcription and translation machinery of HEVA71 but did not interfere with the viral internal ribosomal entry site (IRES) activity. Hence, our findings strongly suggest that ST077124 and ST024734 are effective antiviral compounds of minimal cytotoxicity and could serve as promising therapeutic agents against HEVA71 infection.


Asunto(s)
Antivirales/farmacología , Enterovirus Humano A/efectos de los fármacos , Enterovirus Humano A/fisiología , Flavonoides/farmacología , Extractos Vegetales/farmacología , Replicación Viral/efectos de los fármacos , Línea Celular , Descubrimiento de Drogas , Evaluación Preclínica de Medicamentos , Regulación Viral de la Expresión Génica/efectos de los fármacos , Ensayos Analíticos de Alto Rendimiento , Humanos , Sitios Internos de Entrada al Ribosoma , Bibliotecas de Moléculas Pequeñas
7.
Methods Mol Biol ; 1426: 263-72, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27233279

RESUMEN

Chikungunya virus (CHIKV) is the etiologic agent of Chikungunya fever and has emerged in many countries over the past decade. There are no effective drugs for controlling the disease. A bicistronic baculovirus expression system was utilized to co-express CHIKV structural proteins C (capsid), E2 and E1 and the enhanced green fluorescence protein (EGFP) in Spodoptera frugiperda insect cells (Sf21). The EGFP-positive Sf21 cells fused with each other and with uninfected cells to form a syncytium is mediated by the CHIKV E1 allowing it to identify chemicals that can prevent syncytium formation. The compounds characterized by this method could be anti-CHIKV drugs.


Asunto(s)
Antivirales/farmacología , Baculoviridae/genética , Proteínas de la Cápside/genética , Virus Chikungunya/efectos de los fármacos , Proteínas del Envoltorio Viral/genética , Animales , Baculoviridae/metabolismo , Proteínas de la Cápside/metabolismo , Fusión Celular , Virus Chikungunya/genética , Evaluación Preclínica de Medicamentos , Vectores Genéticos/genética , Células Gigantes/efectos de los fármacos , Proteínas Fluorescentes Verdes/genética , Proteínas Fluorescentes Verdes/metabolismo , Sitios Internos de Entrada al Ribosoma/efectos de los fármacos , Células Sf9 , Proteínas del Envoltorio Viral/metabolismo
8.
Biochim Biophys Acta ; 1861(5): 471-81, 2016 May.
Artículo en Inglés | MEDLINE | ID: mdl-26869449

RESUMEN

Non-alcoholic fatty liver disease (NAFLD) is a chronic disease characterized by accumulation of lipid droplets in hepatocytes. Enhanced release of non-esterified fatty acids from adipose tissue accounts for a remarkable fraction of accumulated lipids. However, the de novo lipogenesis (DNL) is also implicated in the etiology of the NAFLD. Sterol Regulatory Element-Binding Protein-1 (SREBP-1) is a transcription factor modulating the expression of several lipogenic enzymes. In the present study, in order to investigate the effect of lipid droplet accumulation on DNL, we used a cellular model of steatosis represented by HepG2 cells cultured in a medium supplemented with free oleic and palmitic fatty acids (FFAs). We report that FFA supplementation induces the expression of genes coding for enzymes involved in the DNL as well as for the transcription factor SREBP-1a. The SREBP-1a mRNA translation, dependent on an internal ribosome entry site (IRES), and the SREBP-1a proteolytic cleavage are activated by FFAs. Furthermore, FFA treatment enhances the expression and the nucleus-cytosolic shuttling of hnRNP A1, a trans-activating factor of SREBP-1a IRES. The binding of hnRNP A1 to the SREBP-1a IRES is also increased upon FFA supplementation. The relocation of hnRNP A1 and the consequent increase of SREBP-1a translation are dependent on the p38 MAPK signal pathway, which is activated by FFAs. By RNA interference approach, we demonstrate that hnRNP A1 is implicated in the FFA-induced expression of SREBP-1a and of its target genes as well as in the lipid accumulation in cells.


Asunto(s)
Regiones no Traducidas 5' , Hepatocitos/metabolismo , Ribonucleoproteína Heterogénea-Nuclear Grupo A-B/metabolismo , Lipogénesis , Hígado/metabolismo , Enfermedad del Hígado Graso no Alcohólico/metabolismo , ARN Mensajero/metabolismo , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/biosíntesis , Sitios de Unión , Regulación de la Expresión Génica , Células Hep G2 , Hepatocitos/efectos de los fármacos , Hepatocitos/patología , Ribonucleoproteína Nuclear Heterogénea A1 , Ribonucleoproteína Heterogénea-Nuclear Grupo A-B/genética , Humanos , Sitios Internos de Entrada al Ribosoma , Lipogénesis/efectos de los fármacos , Lipogénesis/genética , Hígado/efectos de los fármacos , Hígado/patología , Enfermedad del Hígado Graso no Alcohólico/genética , Enfermedad del Hígado Graso no Alcohólico/patología , Ácido Oléico/farmacología , Ácido Palmítico/farmacología , Transporte de Proteínas , Interferencia de ARN , ARN Mensajero/genética , Transducción de Señal , Proteína 1 de Unión a los Elementos Reguladores de Esteroles/genética , Factores de Tiempo , Transfección , Proteínas Quinasas p38 Activadas por Mitógenos/metabolismo
9.
Endocrinology ; 156(12): 4769-80, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26402844

RESUMEN

Transgenic mice, including lines targeting corticotropin-releasing factor (CRF or CRH), have been extensively employed to study stress neurobiology. These powerful tools are poised to revolutionize our understanding of the localization and connectivity of CRH-expressing neurons, and the crucial roles of CRH in normal and pathological conditions. Accurate interpretation of studies using cell type-specific transgenic mice vitally depends on congruence between expression of the endogenous peptide and reporter. If reporter expression does not faithfully reproduce native gene expression, then effects of manipulating unintentionally targeted cells may be misattributed. Here, we studied CRH and reporter expression patterns in 3 adult transgenic mice: Crh-IRES-Cre;Ai14 (tdTomato mouse), Crfp3.0CreGFP, and Crh-GFP BAC. We employed the CRH antiserum generated by Vale after validating its specificity using CRH-null mice. We focused the analyses on stress-salient regions, including hypothalamus, amygdala, bed nucleus of the stria terminalis, and hippocampus. Expression patterns of endogenous CRH were consistent among wild-type and transgenic mice. In tdTomato mice, most CRH-expressing neurons coexpressed the reporter, yet the reporter identified a few non-CRH-expressing pyramidal-like cells in hippocampal CA1 and CA3. In Crfp3.0CreGFP mice, coexpression of CRH and the reporter was found in central amygdala and, less commonly, in other evaluated regions. In Crh-GFP BAC mice, the large majority of neurons expressed either CRH or reporter, with little overlap. These data highlight significant diversity in concordant expression of reporter and endogenous CRH among 3 available transgenic mice. These findings should be instrumental in interpreting important scientific findings emerging from the use of these potent neurobiological tools.


Asunto(s)
Encéfalo/metabolismo , Hormona Liberadora de Corticotropina/genética , Genes Reporteros/genética , Neuronas/metabolismo , ARN Mensajero/metabolismo , Amígdala del Cerebelo/metabolismo , Animales , Proteínas Fluorescentes Verdes , Hipocampo/metabolismo , Hipotálamo/metabolismo , Sitios Internos de Entrada al Ribosoma , Masculino , Ratones , Ratones Transgénicos , Núcleo Hipotalámico Paraventricular/citología , Núcleo Hipotalámico Paraventricular/metabolismo , Núcleos Septales/metabolismo , Transcriptoma
10.
Biotechniques ; 59(3): 149-51, 2015 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-26345507

RESUMEN

Cell-free protein synthesis (CFPS) allows researchers to rapidly generate functional proteins independent of cell culture. Although advances in eukaryotic lysates have increased the amount of protein that can be produced, the nuances of different translation systems lead to variability in protein production. To help overcome this problem, we have compared the relative yield and template requirements for three commonly used commercial cell-free translation systems: wheat germ extract (WGE), rabbit reticulocyte lysate (RRL), and HeLa cell lysate (HCL). Our results provide a general guide for researchers interested in using cell-free translation to generate recombinant protein for biomedical applications.


Asunto(s)
Sistema Libre de Células , Biosíntesis de Proteínas , Ingeniería de Proteínas/métodos , Proteínas Recombinantes/biosíntesis , Regiones no Traducidas 5' , Animales , Células HeLa , Humanos , Sitios Internos de Entrada al Ribosoma , Extractos Vegetales/metabolismo , Conejos , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Reticulocitos , Triticum
11.
Int J Mol Sci ; 16(4): 8789-810, 2015 Apr 20.
Artículo en Inglés | MEDLINE | ID: mdl-25903151

RESUMEN

Overexpression of the amyloid precursor protein (APP) and the hyperphosphorylation of the tau protein are vital in the understanding of the cause of Alzheimer's disease (AD). As a consequence, regulation of the expression of both APP and tau proteins is one important approach in combating AD. The APP and tau proteins can be targeted at the levels of transcription, translation and protein structural integrity. This paper reports the utilization of a bi-cistronic vector containing either APP or tau internal ribosome entry site (IRES) elements flanked by ß-galactosidase gene (cap-dependent) and secreted alkaline phosphatase (SEAP) (cap-independent) to discern the mechanism of action of memantine, an N-methyl-D-aspartate (NMDA) receptor antagonist. Results indicate that memantine could reduce the activity of both the APP and tau IRES at a concentration of ~10 µM (monitored by SEAP activity) without interfering with the cap-dependent translation as monitored by the ß-galactosidase assay. Western blot analysis of the tau protein in neuroblastoma (N2A) and rat hippocampal cells confirmed the halting of the expression of the tau proteins. We also employed this approach to identify a preparation named NB34, extracts of Boussingaultia baselloides (madeira-vine) fermented with Lactobacillus spp., which can function similarly to memantine in both IRES of APP and Tau. The water maze test demonstrated that NB34 could improve the spatial memory of a high fat diet induced neurodegeneration in apolipoprotein E-knockout (ApoE-/-) mice. These results revealed that the bi-cistronic vector provided a simple, and effective platform in screening and establishing the mechanistic action of potential compounds for the treatment and management of AD.


Asunto(s)
Enfermedad de Alzheimer/tratamiento farmacológico , Precursor de Proteína beta-Amiloide/genética , Fármacos del Sistema Nervioso Central/farmacología , Medicamentos Herbarios Chinos/farmacología , Sitios Internos de Entrada al Ribosoma , Proteínas tau/genética , Enfermedad de Alzheimer/etiología , Precursor de Proteína beta-Amiloide/metabolismo , Animales , Línea Celular Tumoral , Dieta Alta en Grasa/efectos adversos , Evaluación Preclínica de Medicamentos , Expresión Génica/efectos de los fármacos , Masculino , Memantina/farmacología , Ratones Noqueados , Terapia Molecular Dirigida , Especificidad de Órganos , Aprendizaje Espacial/efectos de los fármacos , Proteínas tau/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA